Genomma Lab Internacional
$12.83Change from previous close: +2.15%Absolute change: +$0.27
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- $12.53B
- Enterprise value
- $17.94B
- P/E (trailing 12 months)
- 7.72
- Forward P/E
- 6.49
- PEG
- 0.47
- Price/book
- 1.06
- Price/sales
- 0.74
- EV/EBITDA
- 4.60
- EV/revenue
- 1.05
Profitability and growth
- Gross margin
- 63.3%
- Operating margin
- 20.0%
- Net margin
- 9.6%
- ROE
- 14.2%
- ROA
- 9.1%
- Revenue growth (year over year)
- -6.0%
- Earnings growth (year over year)
- 3.9%
Financial health
- Total cash
- $2.41B
- Total debt
- $7.85B
- Debt/equity
- 0.67
- Current ratio
- 1.41
- Quick ratio
- 1.13
Dividends
- Annual dividend per share
- $0.80
- Dividend yield
- 6.2%
- Payout ratio
- 48.1%
- Ex-dividend date
- September 29, 2026
Analysts and estimates
- Average price target
- $21.67
- Median price target
- $20.50
- High price target
- $29.00
- Low price target
- $16.00
- Analysts with a price target
- 6
- Forward EPS
- $1.98
- EPS estimate, current year
- $1.89
Shares and trading
- Beta
- 0.12
- Average volume
- 3.34M
- Shares outstanding
- 977.75M
- Float
- 672.56M
- Institutional ownership
- 32.2%
- Insider ownership
- 31.1%